CellCept or Imuran: Which One for Antisynthetase Syndrome?

When treating antisynthetase syndrome (ASS)—a rare autoimmune condition that can cause interstitial lung disease (ILD, inflammation and scarring of the lungs), myositis (muscle weakness), and arthritis (joint inflammation)—doctors often prescribe an immunosuppressant to control the disease.

Two commonly used medications are mycophenolate mofetil (CellCept) and azathioprine (Imuran). Both are considered “steroid-sparing” agents: they calm the immune system over time, which may eventually allow your doctor to safely and gradually lower your daily dose of steroids, such as prednisone ^[1][2].

There is no high-quality, head-to-head clinical trial proving that one of these drugs is universally better than the other for antisynthetase syndrome ^[3]. Because treatment must be highly individualized, doctors choose between them based on which organs are most affected, your risk for certain side effects, required monitoring, and whether you are planning a pregnancy ^[4].

Lungs vs. Muscles: Practice Patterns and Evidence

While both medications can be used for lung, muscle, and joint involvement, doctors often develop practice patterns based on observational studies and clinical experience.

Interstitial Lung Disease (ILD)

For patients whose primary, most urgent symptom is lung involvement, both mycophenolate and azathioprine are accepted options to help stabilize or improve lung function ^[2][1]. A retrospective study of 110 patients with myositis-related ILD found that both drugs helped improve or stabilize Forced Vital Capacity (FVC), a measure of how much air the lungs can hold ^[5].

However, in some clinics, mycophenolate is favored for lung-dominant disease ^[2]. In the retrospective study mentioned above, patients taking azathioprine experienced more adverse events overall (33.3%) compared to those taking mycophenolate (13.6%) ^[5]. Because this was an observational study rather than a controlled trial, it does not guarantee mycophenolate is better tolerated for every patient, but it influences why some doctors prefer it when treating the lungs. Note that the goal of treatment for ILD is often to stabilize the lungs and prevent further scarring, as existing scar tissue may not be reversible.

Muscles and Joints

If severe muscle weakness or joint pain is your main challenge, your doctor might lean toward azathioprine. Observational cohorts have shown azathioprine is effective at improving muscle strength and reducing creatine kinase (CK), an enzyme that leaks into the blood when muscle is damaged ^[6][7]. Mycophenolate can also be used for muscle disease, but direct comparisons between the two for myositis specifically are lacking.

Note: Your own symptoms do not always reliably identify which organ is most affected. Your doctor will use pulmonary function tests, imaging, muscle examinations, and blood work (like CK levels) to assess your condition.

The Pregnancy Difference: A Crucial Distinction

A major difference between these two medications is their safety during pregnancy.

• Mycophenolate is strictly contraindicated during pregnancy. It is teratogenic, meaning it is known to increase the risk of miscarriages and cause a specific pattern of severe birth defects (such as ear, facial, and eye anomalies) ^[8][9]. Anyone taking mycophenolate must use highly effective contraception. If you plan to conceive, guidelines recommend stopping mycophenolate and switching to a safer medication at least six weeks before trying to become pregnant ^[10][8].
• Azathioprine is considered pregnancy-compatible. While no medication is entirely risk-free, azathioprine is frequently used as a maintenance therapy for patients who are pregnant or planning to conceive ^[11][10]. It allows patients to control their disease during pregnancy under the careful supervision of a maternal-fetal medicine specialist.

Never stop either medication abruptly on your own. If you become pregnant or suspect you might be, contact your care team immediately for guidance.

Safety, Side Effects, and Required Monitoring

Because both drugs suppress the immune system, they carry significant safety risks that require ongoing medical monitoring. Both medications can increase your risk for infections, cause low white blood cell counts, and lead to liver abnormalities.

Required Blood Tests

Neither drug is safe to take without regular monitoring. You will need frequent blood tests—including complete blood counts (CBC) and liver function tests (LFTs)—to catch “silent” side effects before they become dangerous. Your doctor will determine the exact schedule, which is usually more frequent when you first start the medication.

Warning Signs

Contact your care team immediately if you develop:

• Fever, severe sore throat, or signs of a new or worsening infection
• Unusual bruising or bleeding
• Yellowing of the skin or eyes (jaundice)
• Severe abdominal pain or persistent diarrhea
• New or rapidly worsening breathlessness (which requires urgent medical evaluation)

Azathioprine and Genetic Testing (TPMT/NUDT15)

Before prescribing azathioprine, doctors usually order a blood test to check for variations in your TPMT and NUDT15 genes or enzymes ^[12][13]. Certain genetic variations make it harder for the body to break down azathioprine, drastically increasing the risk of severe drops in white blood cells (myelotoxicity) ^[14].
Important: Having a normal TPMT or NUDT15 test does not eliminate the risk of low blood counts, liver toxicity, or pancreatitis. Regular blood test monitoring is still mandatory. Additionally, azathioprine can interact dangerously with gout medications like allopurinol or febuxostat, so always ensure your doctor knows every medication you take.

How Your Doctor Monitors Your Progress

These medications do not work overnight. It can take weeks or months to see the full benefit. You should never alter your steroid dose on your own, even if you feel better; steroid tapering must be gradual and supervised based on objective measurements of your disease activity. If your breathing worsens rapidly, or if your muscle weakness progresses quickly, do not wait for a scheduled appointment—seek urgent medical assessment.

Summary Comparison